Skip to content
BY 4.0 license Open Access Published by De Gruyter Open Access November 10, 2023

Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”

  • Sahar K. Hegazy , Samar Tharwat and Ahmed H. Hassan EMAIL logo
From the journal Open Medicine

The publisher would like to inform that the article, Hegazy S., Tharwat S, Hassan A. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients Open Medicine 2023;18(1):20230768, DOI: 10.1515/med-2023-0768, has been retracted.

Editorial Office decided to retract this article due to significant overlap with the other papers published by the same authors in Journal of Clinical Virology Plus: doi.org/10.1016/j.jcvp.2023.100151.


tel: +20-155465810

Received: 2023-10-31
Accepted: 2023-10-31
Published Online: 2023-11-10

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 3.3.2024 from https://www.degruyter.com/document/doi/10.1515/med-2023-0853/html
Scroll to top button